Holen Sie sich die Stockscreener-App
25.10
0.04%
0.010
Handel nachbörslich:
24.60
-0.50
-1.99%
Schlusskurs vom Vortag:
$25.11
Offen:
$25.11
24-Stunden-Volumen:
341.32K
Relative Volume:
1.62
Marktkapitalisierung:
$644.88M
Einnahmen:
-
Nettoeinkommen (Verlust:
$11.77M
KGV:
43.39
EPS:
0.5785
Netto-Cashflow:
$-19.23M
1W Leistung:
+9.08%
1M Leistung:
+16.35%
6M Leistung:
+102.25%
1J Leistung:
+53.64%
1-Tages-Spanne:
$24.69
$25.53
1-Wochen-Bereich:
$22.31
$25.53
52-Wochen-Spanne:
$11.56
$29.79
Tourmaline Bio Inc Stock (TRML) Company Profile
Firmenname
Tourmaline Bio Inc
Sektor
Branche
Telefon
646-481-9832
Adresse
27 WEST 24TH STREET, NEW YORK
Vergleichen Sie TRML mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TRML
Tourmaline Bio Inc
|
25.10 | 605.57M | 0 | 11.77M | -19.23M | 0.5785 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Tourmaline Bio Inc Stock (TRML) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-04-23 | Eingeleitet | Chardan Capital Markets | Buy |
| 2025-03-06 | Eingeleitet | Wedbush | Outperform |
| 2024-12-06 | Eingeleitet | BMO Capital Markets | Outperform |
| 2024-11-11 | Bestätigt | H.C. Wainwright | Buy |
| 2023-12-15 | Eingeleitet | Jefferies | Buy |
| 2023-12-04 | Fortgesetzt | H.C. Wainwright | Buy |
| 2023-11-17 | Eingeleitet | Truist | Buy |
| 2023-10-31 | Eingeleitet | Guggenheim | Buy |
| 2023-10-25 | Eingeleitet | Piper Sandler | Overweight |
| 2022-10-20 | Eingeleitet | H.C. Wainwright | Buy |
| 2022-07-05 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
Alle ansehen
Tourmaline Bio Inc Aktie (TRML) Neueste Nachrichten
What’s next for Tourmaline Bio Inc. stockWatch List & AI Optimized Trade Strategies - khodrobank.com
Technical signs of recovery in Tourmaline Bio Inc2025 Support & Resistance & Growth Focused Stock Pick Reports - Newser
Will Tourmaline Bio Inc. stock go up soonJuly 2025 PostEarnings & AI Driven Stock Price Forecasts - Newser
When is the best time to exit Tourmaline Bio Inc.July 2025 Outlook & AI Enhanced Trading Signals - Newser
Technical signs of recovery in Tourmaline Bio Inc.July 2025 Retail & Safe Swing Trade Setups - Newser
Relative strength of Tourmaline Bio Inc. in sector analysisEarnings Overview Summary & Stock Portfolio Risk Management - Newser
Applying big data sentiment scoring on Tourmaline Bio Inc.2025 Key Lessons & Growth Focused Entry Reports - Newser
Can you recover from losses in Tourmaline Bio Inc.Earnings Growth Summary & Weekly High Conviction Ideas - Newser
How hedge fund analytics apply to Tourmaline Bio Inc. stockTreasury Yields & High Accuracy Investment Entry Signals - Newser
Is Tourmaline Bio Inc. a candidate for recovery playWeekly Trend Summary & Real-Time Stock Price Movement Reports - Newser
Risk adjusted return profile for Tourmaline Bio Inc. analyzedJuly 2025 Institutional & Real-Time Chart Pattern Alerts - Newser
Risk vs reward if holding onto Tourmaline Bio Inc.Quarterly Trade Report & Growth Focused Entry Reports - Newser
Is now a turning point for Tourmaline Bio Inc.Portfolio Update Summary & Low Drawdown Trading Strategies - Newser
Predicting Tourmaline Bio Inc. trend using moving averagesBull Run & Technical Confirmation Trade Alerts - Newser
Key resistance and support levels for Tourmaline Bio Inc.July 2025 Patterns & Precise Swing Trade Entry Alerts - Newser
Using portfolio simulators with Tourmaline Bio Inc. includedQuarterly Portfolio Report & Community Supported Trade Ideas - Newser
How high can Tourmaline Bio Inc. stock go2025 Big Picture & Reliable Intraday Trade Plans - Newser
Will Tourmaline Bio Inc. Sustain Its Chart BreakoutEarnings Trend Report & Verified High Yield Trade Plans - beatles.ru
Multi factor analysis applied to Tourmaline Bio Inc.July 2025 Spike Watch & Community Consensus Trade Signals - Newser
Is Tourmaline Bio Inc. stock ready for a breakoutM&A Rumor & Stock Portfolio Risk Control - Newser
Is Tourmaline Bio Inc. part of any ETFJuly 2025 Setups & AI Optimized Trade Strategies - khodrobank.com
What moving averages say about Tourmaline Bio Inc.2025 EndofYear Setup & Safe Capital Allocation Plans - Newser
Is Tourmaline Bio Inc.’s growth already priced inExit Point & Reliable Price Breakout Signals - khodrobank.com
Tourmaline Bio Inc. Flashes Rebound Signal in Oversold Condition getLinesFromResByArray error: size == 0 - thegnnews.com
Is Tourmaline Bio Inc. a good stock for dollar cost averagingJuly 2025 Sector Moves & Verified Momentum Watchlists - khodrobank.com
Is Tourmaline Bio Inc. still worth holding after the dipJuly 2025 EndofMonth & Free Low Drawdown Momentum Trade Ideas - Newser
Is Tourmaline Bio Inc. stock entering bullish territoryWeekly Profit Report & Weekly Breakout Opportunity Watchlist - Newser
Tourmaline Bio Reports Positive Phase 2 Trial Results and Receives Optimistic Analyst Predictions - AInvest
Tourmaline Bio Presents Data from the Ongoing Phase 2 TRANQUILITY Trial at the 2025 European Society of Cardiology Congress - The Manila Times
First-Ever 85% CRP Reduction with Quarterly Dosing: Tourmaline's Breakthrough in Heart Disease Trial - Stock Titan
Tourmaline Bio Inc. Stock Fails to Break Resistance Traders ReactJuly 2025 Trade Ideas & High Yield Stock Recommendations - beatles.ru
Multi asset correlation models including Tourmaline Bio Inc.July 2025 Opening Moves & Capital Protection Trade Alerts - Newser
Real time breakdown of Tourmaline Bio Inc. stock performance2025 Support & Resistance & High Yield Stock Recommendations - Newser
What to do if you’re stuck in Tourmaline Bio Inc.Weekly Investment Summary & Community Consensus Stock Picks - Newser
Finanzdaten der Tourmaline Bio Inc-Aktie (TRML)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.75%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):